Roles of Adrenergic α1 and Dopamine D1 and D2 Receptors in the Mediation of the Desynchronization Effects of Modafinil in a Mouse EEG Synchronization Model

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Chen, Chang Rui ^a   Yang, Su Rong ^a   Liu, Yuan Yuan ^a   Qu, Wei Min ^a   Urade, Yoshihiro ^b   Huang, Zhi Li ^a  

^a FUDAN UNIVERSITY   (China)

^b OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA 1 ADRENERGIC RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MODAFINIL; RACLOPRIDE; RESERPINE; SCOPOLAMINE; TERAZOSIN;

ADRENERGIC ACTIVITY; ALPHA RHYTHM; AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ARTICLE; BETA RHYTHM; CATECHOLAMINE RELEASE; CONTROLLED STUDY; DELTA RHYTHM; DENSITY; DOPAMINERGIC ACTIVITY; ELECTROENCEPHALOGRAPHY PHASE SYNCHRONIZATION; FREQUENCY MODULATION; MALE; MOUSE; NONHUMAN; THETA RHYTHM;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BENZHYDRYL COMPOUNDS; CEREBRAL CORTEX; CHOLINERGIC ANTAGONISTS; CORTICAL SYNCHRONIZATION; DOPAMINE ANTAGONISTS; ELECTROENCEPHALOGRAPHY; MALE; MICE; RACLOPRIDE; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RESERPINE; SCOPOLAMINE HYDROBROMIDE; WAKEFULNESS-PROMOTING AGENTS;

EID: 84885083117     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076102     Document Type: Article

References (50)

1. Beck C, Silverstone P, Glor K, Dunn J, (1999) Psychostimulant prescriptions by psychiatrists higher than expected: a self-report survey. Can J Psychiatry 44: 680-684.
2. Tiligada E, Kyriakidis K, Chazot PL, Passani MB, (2011) Histamine pharmacology and new CNS drug targets. CNS Neurosci Ther 17: 620-628.
3. Echeverria V, Zeitlin R, (2012) Cotinine: a potential new therapeutic agent against Alzheimer's disease. CNS Neurosci Ther 18: 517-523.
4. Qu WM, Huang ZL, Xu XH, Matsumoto N, Urade Y, (2008) Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil. J Neurosci 28: 8462-8469.
5. Minzenberg MJ, Carter CS, (2008) Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology 33: 1477-1502.
6. Jasinski DR, Kovacevic-Ristanovic R, (2000) Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy. Clin Neuropharmacol 23: 149-156.
7. Ghahremani DG, Tabibnia G, Monterosso J, Hellemann G, Poldrack RA, et al. (2011) Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals. Neuropsychopharmacology 36: 950-959.
8. Sahakian B, Morein-Zamir S, (2007) Professor's little helper. Nature 450: 1157-1159.
9. Greely H, Sahakian B, Harris J, Kessler RC, Gazzaniga M, et al. (2008) Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 456: 702-705.
10. Sofuoglu M, DeVito EE, Waters AJ, Carroll KM, (2013) Cognitive enhancement as a treatment for drug addictions. Neuropharmacology 64: 452-463.
11. Banjo OC, Nadler R, Reiner PB, (2010) Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount. PLoS One 5: e14322.
12. Kelley AM, Webb CM, Athy JR, Ley S, Gaydos S, (2012) Cognition enhancement by modafinil: a meta-analysis. Aviat Space Environ Med 83: 685-690.
13. Dringenberg HC, Diavolitsis P, Noseworthy PA, (2000) Effect of tacrine on EEG slowing in the rat: enhancement by concurrent monoamine therapy. Neurobiol Aging 21: 135-143.
14. Dringenberg HC, Rubenstein ML, Solty H, Tomaszek S, Bruce A, (2002) Electroencephalographic activation by tacrine, deprenyl, and quipazine: cholinergic vs. non-cholinergic contributions. Eur J Pharmacol 447: 43-50.
15. Mignot E, Nishino S, Guilleminault C, Dement WC, (1994) Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 17: 436-437.
16. Chen C, Tan R, Qu W, Wu Z, Wang Y, et al. (2011) Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, exerts antiepileptic effects via the GABA/benzodiazepine receptor complex in mice. Br J Pharmacol 164: 1534-1546.
17. Oishi Y, Huang ZL, Fredholm BB, Urade Y, Hayaishi O, (2008) Adenosine in the tuberomammillary nucleus inhibits the histaminergic system via A1 receptors and promotes non-rapid eye movement sleep. Proc Natl Acad Sci U S A 105: 19992-19997.
18. Chen CR, Zhou XZ, Luo YJ, Huang ZL, Urade Y, et al. (2012) Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, induces sleep via the benzodiazepine site of GABA(A) receptor in mice. Neuropharmacology 63: 1191-1199.
19. Franklin KBJ PG (1997) The Mouse Brain in Stereotaxic Coordinates (Academic, San Diego).
20. Liu Z, Xu XH, Liu TY, Hong ZY, Urade Y, et al. (2012) Safranal enhances non-rapid eye movement sleep in pentobarbital-treated mice. CNS Neurosci Ther 18: 623-630.
21. Steriade M, Datta S, Pare D, Oakson G, Curro Dossi RC, (1990) Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems. J Neurosci 10: 2541-2559.
22. Steriade M, Amzica F, Nunez A, (1993) Cholinergic and noradrenergic modulation of the slow (approximately 0.3 Hz) oscillation in neocortical cells. J Neurophysiol 70: 1385-1400.
23. Steriade M, McCormick DA, Sejnowski TJ, (1993) Thalamocortical oscillations in the sleeping and aroused brain. Science 262: 679-685.
24. Stewart DJ, MacFabe DF, Vanderwolf CH, (1984) Cholinergic activation of the electrocorticogram: role of the substantia innominata and effects of atropine and quinuclidinyl benzilate. Brain Res 322: 219-232.
25. Gozzi A, Colavito V, Seke Etet PF, Montanari D, Fiorini S, et al. (2012) Modulation of fronto-cortical activity by modafinil: a functional imaging and fos study in the rat. Neuropsychopharmacology 37: 822-837.
26. Sebban C, Zhang XQ, Tesolin-Decros B, Millan MJ, Spedding M, (1999) Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission. Br J Pharmacol 128: 1045-1054.
27. Manni R, Terzaghi M, (2005) Rhythmic movements during sleep: a physiological and pathological profile. Neurol Sci 26Suppl 3: s181-185.
28. Nishida N, Huang ZL, Mikuni N, Miura Y, Urade Y, et al. (2007) Deep brain stimulation of the posterior hypothalamus activates the histaminergic system to exert antiepileptic effect in rat pentylenetetrazol model. Exp Neurol 205: 132-144.
29. Shi LH, Luo F, Woodward D, Chang JY, (2006) Deep brain stimulation of the substantia nigra pars reticulata exerts long lasting suppression of amygdala-kindled seizures. Brain Res 1090: 202-207.
30. Velasco M, Velasco F, Velasco AL, Jimenez F, Brito F, et al. (2000) Acute and chronic electrical stimulation of the centromedian thalamic nucleus: modulation of reticulo-cortical systems and predictor factors for generalized seizure control. Arch Med Res 31: 304-315.
31. Chen CR, Qu WM, Qiu MH, Xu XH, Yao MH, et al. (2007) Modafinil exerts a dose-dependent antiepileptic effect mediated by adrenergic alpha1 and histaminergic H1 receptors in mice. Neuropharmacology 53: 534-541.
32. Gingrich JA, Caron MG, (1993) Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci 16: 299-321.
33. Kobayashi M, Iaccarino C, Saiardi A, Heidt V, Bozzi Y, et al. (2004) Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice. Proc Natl Acad Sci U S A 101: 11465-11470.
34. Kropf W, Kuschinsky K, (1993) Effects of stimulation of dopamine D1 receptors on the cortical EEG in rats: different influences by a blockade of D2 receptors and by an activation of putative dopamine autoreceptors. Neuropharmacology 32: 493-500.
35. Ongini E, Caporali MG, Massotti M, (1985) Stimulation of dopamine D-1 receptors by SKF 38393 induces EEG desynchronization and behavioral arousal. Life Sci 37: 2327-2333.
36. Usiello A, Baik JH, Rouge-Pont F, Picetti R, Dierich A, et al. (2000) Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408: 199-203.
37. Monti JM, Hawkins M, Jantos H, D'Angelo L, Fernandez M, (1988) Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Psychopharmacology (Berl) 95: 395-400.
38. Ongini E, Bonizzoni E, Ferri N, Milani S, Trampus M, (1993) Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat. J Pharmacol Exp Ther 266: 726-731.
39. Kropf W, Kuschinsky K, (1991) Electroencephalographic correlates of the sedative effects of dopamine agonists presumably acting on autoreceptors. Neuropharmacology 30: 953-960.
40. Gessa GL, Porceddu ML, Collu M, Mereu G, Serra M, et al. (1985) Sedation and sleep induced by high doses of apomorphine after blockade of D-1 receptors by SCH 23390. Eur J Pharmacol 109: 269-274.
41. Qu WM, Xu XH, Yan MM, Wang YQ, Urade Y, et al. (2010) Essential role of dopamine D2 receptor in the maintenance of wakefulness, but not in homeostatic regulation of sleep, in mice. J Neurosci 30: 4382-4389.
42. Lazarus M, Chen JF, Urade Y, Huang ZL (2013) Role of the basal ganglia in the control of sleep and wakefulness. Curr Opin Neurobiol.
43. Lazarus M, Huang ZL, Lu J, Urade Y, Chen JF, (2012) How do the basal ganglia regulate sleep-wake behavior? Trends Neurosci 35: 723-732.
44. Madras BK, Xie Z, Lin Z, Jassen A, Panas H, et al. (2006) Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther 319: 561-569.
45. Gallopin T, Luppi PH, Rambert FA, Frydman A, Fort P, (2004) Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study. Sleep 27: 19-25.
46. Duteil J, Rambert FA, Pessonnier J, Hermant JF, Gombert R, et al. (1990) Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur J Pharmacol 180: 49-58.
47. de Saint Hilaire Z, Orosco M, Rouch C, Blanc G, Nicolaidis S, (2001) Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats. Neuroreport 12: 3533-3537.
48. Stone EA, Cotecchia S, Lin Y, Quartermain D, (2002) Role of brain alpha 1B-adrenoceptors in modafinil-induced behavioral activity. Synapse 46: 269-270.
49. Minzenberg MJ, Watrous AJ, Yoon JH, Ursu S, Carter CS, (2008) Modafinil shifts human locus coeruleus to low-tonic, high-phasic activity during functional MRI. Science 322: 1700-1702.
50. Wisor JP, Eriksson KS, (2005) Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil. Neuroscience 132: 1027-1034.